Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an effective cure for beta-thalassemia and sickle cell disease in children younger than 12. Researchers say the therapy's potential to offer a cure at an early age—before organ damage accumulates—could make exa-cel even more beneficial in children than adults.
from Medical Xpress - latest medical and health news stories https://ift.tt/K1ZxG95
